Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Sidoni

Showing results (141-150 of 152) with videos related to

Pageof 16
Sort By:
Oncotarget|November 7, 2014
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancerEmilio Bria, Francesca Di Modugno, Isabella Sperduti, et al.
Journal of the National Cancer Institute|May 5, 2005
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancerFederico Cappuzzo, Fred R Hirsch, Elisa Rossi, et al.
Pathology|February 29, 2020
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targetsAnna Caliò, Matteo Brunelli, Diego Segala, et al.
The American Journal of Surgical Pathology|May 14, 2015
KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based studySabrina Rossi, Daniela Gasparotto, Rosalba Miceli, et al.
Genes|May 5, 2021
Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with <i>EGFR</i> Exon 20 Insertion MutationsGiulio Metro, Sara Baglivo, Guido Bellezza, et al.
Tumori|June 6, 2015
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrenceGiuseppe Bogina, Gianluigi Lunardi, Francesca Coati, et al.
The American Journal of Pathology|January 17, 2009
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissuesMaria Paola Martelli, Gabriella Sozzi, Luis Hernandez, et al.
Clinical and Translational Medicine|July 15, 2022
Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biologySamuel V Rasmussen, Jia Xiang Jin, Lissett R Bickford, et al.
Journal for Immunotherapy of Cancer|October 8, 2021
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicineElisa Baldelli, K Alex Hodge, Guido Bellezza, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 18, 2017
Erratum to: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phaseFranco Di Filippo, Simona Di Filippo, Anna Maria Ferrari, et al.
Pageof 16

Showing results (141-150 of 152) with videos related to

Sort By:
Pageof 16
Oncotarget|November 7, 2014
Prognostic impact of alternative splicing-derived hMENA isoforms in resected, node-negative, non-small-cell lung cancerEmilio Bria, Francesca Di Modugno, Isabella Sperduti, et al.
Journal of the National Cancer Institute|May 5, 2005
Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancerFederico Cappuzzo, Fred R Hirsch, Elisa Rossi, et al.
Pathology|February 29, 2020
Comprehensive analysis of 34 MiT family translocation renal cell carcinomas and review of the literature: investigating prognostic markers and therapy targetsAnna Caliò, Matteo Brunelli, Diego Segala, et al.
The American Journal of Surgical Pathology|May 14, 2015
KIT, PDGFRA, and BRAF mutational spectrum impacts on the natural history of imatinib-naive localized GIST: a population-based studySabrina Rossi, Daniela Gasparotto, Rosalba Miceli, et al.
Genes|May 5, 2021
Sensitivity to Immune Checkpoint Blockade in Advanced Non-Small Cell Lung Cancer Patients with <i>EGFR</i> Exon 20 Insertion MutationsGiulio Metro, Sara Baglivo, Guido Bellezza, et al.
Tumori|June 6, 2015
Progesterone receptor status and clinical outcome in breast cancer patients with estrogen receptor-positive locoregional recurrenceGiuseppe Bogina, Gianluigi Lunardi, Francesca Coati, et al.
The American Journal of Pathology|January 17, 2009
EML4-ALK rearrangement in non-small cell lung cancer and non-tumor lung tissuesMaria Paola Martelli, Gabriella Sozzi, Luis Hernandez, et al.
Clinical and Translational Medicine|July 15, 2022
Functional genomic analysis of epithelioid sarcoma reveals distinct proximal and distal subtype biologySamuel V Rasmussen, Jia Xiang Jin, Lissett R Bickford, et al.
Journal for Immunotherapy of Cancer|October 8, 2021
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicineElisa Baldelli, K Alex Hodge, Guido Bellezza, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 18, 2017
Erratum to: Elaboration of a nomogram to predict nonsentinel node status in breast cancer patients with positive sentinel node, intraoperatively assessed with one step nucleic amplification: Retrospective and validation phaseFranco Di Filippo, Simona Di Filippo, Anna Maria Ferrari, et al.
Pageof 16